BioWorld Science

Oct. 20, 2005

View Archived Issues

AZD-103 enters clinic for Alzheimer's disease

Read More

Insmed submits response to iPlex approvable letter

Read More

InterMune updates status of IPF programs for pirfenidone and Actimmune

Read More

Schering AG and Sonus sign agreement for Tocosol Paclitaxel

Read More

Obesity drug AOD-9604 begins new phase IIb study

Read More

TB Alliance and Bayer team up to study moxifloxacin for TB

Read More

Private placement raises funds to support development of Tigris' A-007

Read More

EGEN-001 studied in phase I trial for ovarian cancer

Read More

DDP-225 begins phase II trial for diarrhea-predominant IBS

Read More

AG-707 begins phase I trial for genital herpes

Read More

First patients enrolled in IRX-2 phase II head and neck cancer trial

Read More

Topigen advances ASM-8 into phase II for allergic asthma

Read More

Simvastatin clinically beneficial for PCOS

Read More

FR-167356's potential for clinical application in osteoporosis

Read More

Phase I data on teverelix for reproductive use

Read More

Ghrelin: a novel therapeutic approach for COPD-associated cachexia

Read More

Havrix approved for children aged 12 months and older

Read More

Allos withdraws Revaproxyn MAA in Europe

Read More

Approvable letter for Pargluva

Read More

Long-lasting responses to rituximab seen in pemphigus patients / News in Context

Read More

Pegaptanib beneficial in early age-related macular degeneration

Read More

Metastatic melanoma responses seen with anti-CTLA-4 antibody and peptide vaccine

Read More

New agents for treating obesity disclosed in recent AstraZeneca patent

Read More

Novel antidiabetic agents reported in recent patent literature

Read More

Novel treatment options for hepatitis C imparted in recent literature

Read More